Clinical Trials on Glabellar Crease in New Zealand
Total 2404 results
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | HER2-negative Breast Cancer | ER+ Breast Cancer | HER2 Negative Breast CarcinomaUnited States
-
Vardhman Mahavir Medical College And Safdarjung...Completed
-
Gary SchwartzUniversity of Colorado, Denver; North Shore University HospitalTerminatedMetastatic Breast CancerUnited States
-
Alaunos TherapeuticsTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer ScreeningUnited States
-
PfizerCompleted
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
GlaxoSmithKlineCompleted
-
University of VermontDartmouth-Hitchcock Medical Center; Maimonides Medical CenterUnknownBreast CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Relay Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMemorial University Medical CenterActive, not recruiting
-
Mridula George, MDActive, not recruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
PfizerActive, not recruitingA Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast CancerBreast Cancer | Malignant Neoplasm of BreastUnited States
-
NYU Langone HealthCompleted
-
Memorial Sloan Kettering Cancer CenterPfizer; AmgenCompletedDose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityBreast Cancer | Adenocarcinoma of the BreastUnited States
-
Providence Health & ServicesBristol-Myers Squibb; Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Breast Carcinoma | Breast Neoplasm Female | Breast TumorUnited States
-
Amy TierstenNovartisCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Katherine D. CrewCompletedBreast Neoplasms | Stage 0 Breast Carcinoma | Stage I Breast Carcinoma | Stage II Breast Carcinoma | Stage III Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Invasive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
PfizerCompletedMetastatic HER2+ Advanced Breast CancerUnited States
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage 0United States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)RecruitingMetastatic Breast Cancer | Stage IV Breast Cancer AJCC V7United States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Mridula George, MDRecruiting
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; University of British Columbia; University of Pittsburgh and other collaboratorsCompletedBreast Surgery | Breast Cancer | Breast Augmentation | Breast Reconstruction | Breast ReductionUnited States, Canada
-
Samsung MedisonUniversity of RochesterUnknownBreast Cancer | Breast Lesions | Breast MassUnited States
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical CenterActive, not recruitingLocally Recurrent/Metastatic Triple Negative Breast CancerUnited States
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Dawn L. HershmanNational Cancer Institute (NCI); Incyte CorporationCompletedMetastatic Breast Cancer | Breast Carcinoma | HER-2 Positive Breast CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | Lobular Breast Carcinoma | Postmenopausal | Ductal Breast Carcinoma | Ductal Breast Carcinoma In SituUnited States
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research Institute; Washington University School... and other collaboratorsCompleted
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Icahn School of Medicine at Mount SinaiChampions OncologyCompletedTriple Negative Breast CancerUnited States
-
Columbia UniversityAstellas Pharma Inc; Susan G. Komen Breast Cancer FoundationCompleted
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | ER+ Breast Cancer | Metastatic Breast Carcinoma | HER2+ Breast Cancer | Oligometastatic Breast CarcinomaUnited States